Investigating the role of Hhex protein in T cell development
Homeobox protein Hhex in early T cell development
This study is looking at how a protein called Hhex helps shape the development of T cells from stem cells, which could lead to better treatments for immune-related conditions by improving our understanding of how T cells are made and work.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-11127983 on NIH RePORTER |
What this research studies
This research focuses on understanding how the Hhex protein influences the development of T cells from hematopoietic stem cells. It explores the dual role of Hhex in regulating the differentiation of these cells, particularly during early stages of T cell development. By examining the mechanisms through which Hhex operates, the research aims to clarify its impact on the speed of T cell lineage commitment and the establishment of memory B cells. Patients may benefit from insights gained into T cell production and function, which could lead to improved treatments for immune-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions affecting T cell function or development, such as certain immunodeficiencies or cancers.
Not a fit: Patients with fully functional immune systems or those not affected by T cell-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of T cell development, potentially leading to better therapies for immune disorders and cancers.
How similar studies have performed: Previous research has shown promising results in understanding the roles of various proteins in T cell development, suggesting that this approach could yield valuable insights.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Rothenberg, Ellen V. — California Institute of Technology
- Study coordinator: Rothenberg, Ellen V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.